Adaptimmune Therapeutics PLC ADR | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
247.20
51,475.00
247,439.80
183,387.80
208,261.00
205,134
Total Accounts Receivable
910.00
1,896.20
11,689.50
1,495.60
11,660.00
18,156
Other Current Assets
441.40
928.40
6,068.00
15,964.70
10,262.00
7,805
Total Current Assets
1,598.60
54,299.70
265,197.40
200,848.10
230,183.00
231,095
Net Property, Plant & Equipment
207.80
1,436.30
13,148.70
28,193.40
40,679.00
36,118
Total Investments and Advances
-
-
4,480.70
4,059.40
4,253.00
4,097
Intangible Assets
-
-
2,753.20
1,281.40
1,337.00
1,473
Other Assets
-
-
4,709.10
2,607.20
4,695.00
3,953
Total Assets
1,806.40
55,736.00
290,289.00
236,989.50
281,147.00
276,736
ST Debt & Current Portion LT Debt
1,533.40
-
-
-
-
Accounts Payable
1,911.00
1,017.40
7,836.70
11,469.80
8,378.00
Income Tax Payable
-
75.20
-
2,035.30
-
Other Current Liabilities
512.60
52,223.90
19,887.30
27,189.90
65,936.00
Total Current Liabilities
3,957.10
53,316.50
27,724.10
40,694.90
74,314.00
Other Liabilities
-
-
26,490.40
28,399.50
3,849.00
Total Liabilities
3,957.10
53,316.50
54,214.50
69,094.40
78,163.00
Common Equity (Total)
2,150.70
2,419.40
236,074.60
167,895.10
202,984.00
Total Shareholders' Equity
2,150.70
2,419.40
236,074.60
167,895.10
202,984.00
Total Equity
2,150.70
2,419.40
236,074.60
167,895.10
202,984.00
Liabilities & Shareholders' Equity
1,806.40
55,736.00
290,289.00
236,989.50
281,147.00
About Adaptimmune Therapeutics
View Profile
